X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (222) 222
Publication (41) 41
Newsletter (11) 11
Book Review (5) 5
Data Set (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
riluzole (182) 182
humans (118) 118
index medicus (118) 118
animals (110) 110
amyotrophic lateral sclerosis (81) 81
male (80) 80
neurosciences (70) 70
female (63) 63
pharmacology & pharmacy (63) 63
amyotrophic lateral sclerosis - drug therapy (60) 60
amyotrophic-lateral-sclerosis (59) 59
riluzole - pharmacology (57) 57
clinical neurology (54) 54
riluzole - therapeutic use (54) 54
rats (47) 47
mice (44) 44
neuroprotective agents - therapeutic use (41) 41
glutamate (39) 39
clinical trials (34) 34
pharmacokinetics (34) 34
neuroprotective agents - pharmacology (33) 33
dose-response relationship, drug (32) 32
middle aged (32) 32
drug therapy (31) 31
adult (30) 30
als (29) 29
neurology (28) 28
riluzole - pharmacokinetics (28) 28
aged (27) 27
research (27) 27
spinal cord injuries (27) 27
riluzole - administration & dosage (26) 26
disease models, animal (24) 24
treatment outcome (24) 24
rats, sprague-dawley (23) 23
analysis (22) 22
article (22) 22
neuroprotective agents - pharmacokinetics (22) 22
drugs (20) 20
excitatory amino acid antagonists - pharmacology (20) 20
brain (18) 18
rodents (18) 18
spinal cord injuries - drug therapy (18) 18
spinal cord injury (18) 18
biochemistry & molecular biology (17) 17
disease (17) 17
dosage and administration (17) 17
double-blind method (17) 17
care and treatment (16) 16
clinical trials as topic (16) 16
placebo-controlled trial (16) 16
psychiatry (16) 16
amyotrophic lateral sclerosis - pathology (15) 15
health aspects (15) 15
neuroprotective agents - administration & dosage (15) 15
pharmacology (15) 15
rats, wistar (15) 15
riluzole - adverse effects (15) 15
glutamic acid - metabolism (14) 14
in-vitro (14) 14
mechanisms (14) 14
medicine & public health (14) 14
rat (14) 14
brain - metabolism (13) 13
disease progression (13) 13
double-blind (13) 13
mouse model (13) 13
neurons - drug effects (13) 13
neuroprotection (13) 13
expression (12) 12
metabolism (12) 12
neurons (12) 12
chemistry, medicinal (11) 11
drug interactions (11) 11
inhibition (11) 11
mice, transgenic (11) 11
minocycline (11) 11
model (11) 11
neuroprotective agents - adverse effects (11) 11
original (11) 11
patients (11) 11
persistent sodium current (11) 11
spinal-cord (11) 11
trial (11) 11
adolescent (10) 10
amyotrophic lateral sclerosis - metabolism (10) 10
development and progression (10) 10
excitatory amino acid antagonists - therapeutic use (10) 10
excitotoxicity (10) 10
motor-neuron disease (10) 10
nervous system diseases (10) 10
neuroprotective agent riluzole (10) 10
patch-clamp techniques (10) 10
research article (10) 10
riluzole - blood (10) 10
superoxide dismutase - genetics (10) 10
amyotrophic lateral sclerosis - genetics (9) 9
amyotrophic lateral sclerosis - physiopathology (9) 9
area under curve (9) 9
cell biology (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 12/2018, Volume 125, pp. 1 - 10
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2012, Volume 55, Issue 1, pp. 515 - 527
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2014, Volume 124, Issue 3, pp. 1255 - 1267
Glial glutamate transporter EAAT2 plays a major role in glutamate clearance in synaptic clefts. Several lines of evidence indicate that strategies designed to... 
MEDICINE, RESEARCH & EXPERIMENTAL | RILUZOLE | PROTEIN | MOTOR-NEURON DEGENERATION | INCREASED EXPRESSION | MOUSE MODEL | DISEASE | AMYOTROPHIC-LATERAL-SCLEROSIS | EXCITOTOXIC MECHANISMS | MESSENGER-RNA OXIDATION | ASTROCYTES | Superoxide Dismutase - genetics | Anterior Horn Cells - drug effects | Coculture Techniques | Status Epilepticus - chemically induced | Motor Activity - drug effects | Pyridines - pharmacokinetics | Status Epilepticus - drug therapy | Male | Pilocarpine | Mutation, Missense | Pyridazines - pharmacology | Amyotrophic Lateral Sclerosis - drug therapy | Tissue Distribution | Neuroprotective Agents - pharmacology | Neuroprotective Agents - pharmacokinetics | Protein Kinase C - metabolism | Female | Amyotrophic Lateral Sclerosis - enzymology | Excitatory Amino Acid Transporter 2 - genetics | Superoxide Dismutase - metabolism | Astrocytes - drug effects | Cell Line | Mice, Inbred C57BL | Status Epilepticus - pathology | Rats | Mice, Transgenic | Enzyme Activation - drug effects | Excitatory Amino Acid Transporter 2 - metabolism | Transcription Factors - metabolism | Amyotrophic Lateral Sclerosis - pathology | Animals | Protein Biosynthesis - drug effects | Pyridazines - pharmacokinetics | Mice | Pyridines - pharmacology | Superoxide Dismutase-1 | Astrocytes - metabolism | Carrier proteins | Genetic research | Nervous system | Degeneration | Genetic aspects | Research | Properties | Genetic translation | Identification and classification | Biotechnology | Neurons | Amyotrophic lateral sclerosis | Primaries & caucuses | Kinases | Proteins | Studies | Survival analysis | Transgenic animals | Rodents | Alzheimers disease | Laboratory animals | Chronic illnesses
Journal Article
Neurology, ISSN 0028-3878, 04/2016, Volume 86, Issue 16, pp. 1474 - 1481
Journal Article